A rare germline CDKN2A variant (47T>G; p16-L16R) predisposes carriers to pancreatic cancer by reducing cell cycle inhibition is a research paper published in Journal of Biological Chemistry (2021). On theSindex it has a DataRank of 0.406. It has been cited 14 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.406
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NCI NIH HHS
Grant: R01 CA208517
NCI NIH HHS
Grant: R01 CA097075
NCI NIH HHS
Grant: P50 CA102701
NCI NIH HHS
Grant: P30 CA015083
National Institutes of Health
Grant: 5R01CA097075-05
Pancreatic Cancer Genetic Epidemiology Consortium
National Institutes of Health
Grant: 5R01CA208517-04
Determinants of pancreatic cancer and malignant melanoma phenotypes in CDKN2A hereditary kindreds
National Institutes of Health
Grant: 5P50CA102701-10
Hedgehog EGF Pathway Interaction: Novel Multi-Target Therapy Pancreatic Cancer
NIH
FWCI
0.59
Citation Percentile
0.6%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals